| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHIMERIX INC | 440,000 | 20,328,000 | 8.09% | ||
| 2 | CEMPRA INC | 490,000 | 16,836,000 | 6.70% | ||
| 3 | RETROPHIN INC COM | 460,000 | 15,249,000 | 6.07% | ||
| 4 | AMAG PHARMACEUTICALS INC COM | 190,000 | 13,121,000 | 5.22% | ||
| 5 | ARIAD PHARMACEUTICALS INC | 1,500,000 | 12,405,000 | 4.94% | ||
| 6 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,000 | 11,263,000 | 4.48% | ||
| 7 | IMPRIMIS PHARMACEUTICALS INC | 1,205,000 | 9,797,000 | 3.90% | ||
| 8 | SUPERNUS PHARMACEUTICALS INC COM | 535,000 | 9,084,000 | 3.61% | ||
| 9 | AFFIMED N V | 590,300 | 7,951,000 | 3.16% | ||
| 10 | CLOVIS ONCOLOGY INC | 90,000 | 7,909,000 | 3.15% | ||
| 11 | GERON CORP | 1,825,000 | 7,811,000 | 3.11% | ||
| 12 | FIBROGEN INC COM | 325,000 | 7,638,000 | 3.04% | ||
| 13 | MIMEDX GROUP INC COM | 617,000 | 7,151,000 | 2.85% | ||
| 14 | NEUROCRINE BIOSCIE COM USD0.001 | 145,000 | 6,925,000 | 2.76% | ||
| 15 | CODEXIS INC | 1,724,000 | 6,706,000 | 2.67% | ||
| 16 | AXOGEN INC | 2,120,000 | 6,657,000 | 2.65% | ||
| 17 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 310,000 | 6,569,000 | 2.61% | ||
| 18 | MEDGENICS INC | 1,050,000 | 6,437,000 | 2.56% | ||
| 19 | OPHTHOTECH CORP COM | 105,000 | 5,487,000 | 2.18% | ||
| 20 | TRILLIUM THERAPEUTICS INC | 250,000 | 5,455,000 | 2.17% | ||
| 21 | ZS PHARMA INC | 95,000 | 4,977,000 | 1.98% | ||
| 22 | PROTALIX BIOTHERAPEUTICS INC | 2,505,000 | 4,885,000 | 1.94% | ||
| 23 | AMARIN CORP PLC | 1,754,000 | 4,315,000 | 1.72% | ||
| 24 | CARA THERAPEUTICS INC | 340,000 | 4,131,000 | 1.64% | ||
| 25 | EAGLE PHARMACEUTICALS INC COM | 50,000 | 4,043,000 | 1.61% | ||
| 26 | ADAMAS PHARMACEUTICALS INC | 150,000 | 3,933,000 | 1.56% | ||
| 27 | MACROGENICS INC | 90,000 | 3,417,000 | 1.36% | ||
| 28 | INSYS THERAPEUTICS INC NEW COM NEW | 89,000 | 3,197,000 | 1.27% | ||
| 29 | TETRAPHASE PHARMACEUTICALS I COM | 65,000 | 3,084,000 | 1.23% | ||
| 30 | INOTEK PHARMACEUTICALS CORP | 604,700 | 2,963,000 | 1.18% | ||
| 31 | AVINGER INC | 208,200 | 2,688,000 | 1.07% | ||
| 32 | ACCELERATE DIAGNOSTICS INC | 100,600 | 2,596,000 | 1.03% | ||
| 33 | XOMA CORP DEL | 650,000 | 2,522,000 | 1.00% | ||
| 34 | TENAX THERAPEUTICS INC COM | 635,000 | 2,343,000 | 0.93% | ||
| 35 | AURIS MED HLDG AG | 355,000 | 1,725,000 | 0.69% | ||
| 36 | TONIX PHARMACEUTICALS HLD | 190,000 | 1,704,000 | 0.68% | ||
| 37 | ZOGENIX INC | 912,500 | 1,533,000 | 0.61% | ||
| 38 | Innocoll | 101,200 | 1,481,000 | 0.59% | ||
| 39 | Evoke Pharma Inc | 259,100 | 1,355,000 | 0.54% | ||
| 40 | CELGENE CORP | 456,492 | 950,000 | 0.38% | ||
| 41 | Foamix Pharmaceuticals Ltd. | 85,000 | 871,000 | 0.35% | ||
| 42 | BIOLINERX LTD | 250,000 | 495,000 | 0.20% | ||
| 43 | Agile Therapeutics, Inc. | 55,000 | 472,000 | 0.19% | ||
| 44 | NEURODERM LTD | 26,000 | 399,000 | 0.16% | ||
| 45 | DERMIRA INC | 18,800 | 330,000 | 0.13% | ||
| 46 | TRACON PHARMACEUTICALS INC | 12,172 | 138,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000231, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
